Today's top deals in Healthcare
1/4 Immunitas Therapeutics launched with $39 million in Series A funding. The company’s drug development platform uses single cell genomics-based approaches to discover how immune cells and cells in cancerous tumors interact. #SDG3
-
-
4/4 AN2 Therapeutics raised $12 million in a Series A round led by Mountain Group Partners. The company specializes in R&D and commercialization of novel medications for treating infectious diseases.
#SDG3Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.